Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 41

1.

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008.

Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM.

Int J Cancer. 2010 Dec 15;127(12):2893-917. doi: 10.1002/ijc.25516.

2.

Recent developments in prostate cancer biomarker research: therapeutic implications.

Detchokul S, Frauman AG.

Br J Clin Pharmacol. 2011 Feb;71(2):157-74. doi: 10.1111/j.1365-2125.2010.03766.x. Review.

3.

Reactome: a database of reactions, pathways and biological processes.

Croft D, O'Kelly G, Wu G, Haw R, Gillespie M, Matthews L, Caudy M, Garapati P, Gopinath G, Jassal B, Jupe S, Kalatskaya I, Mahajan S, May B, Ndegwa N, Schmidt E, Shamovsky V, Yung C, Birney E, Hermjakob H, D'Eustachio P, Stein L.

Nucleic Acids Res. 2011 Jan;39(Database issue):D691-7. doi: 10.1093/nar/gkq1018. Epub 2010 Nov 9.

4.

Chlordecone exposure and risk of prostate cancer.

Multigner L, Ndong JR, Giusti A, Romana M, Delacroix-Maillard H, Cordier S, Jégou B, Thome JP, Blanchet P.

J Clin Oncol. 2010 Jul 20;28(21):3457-62. doi: 10.1200/JCO.2009.27.2153. Epub 2010 Jun 21.

PMID:
20566993
5.

Copy number variation in glutathione-S-transferase T1 and M1 predicts incidence and 5-year survival from prostate and bladder cancer, and incidence of corpus uteri cancer in the general population.

Nørskov MS, Frikke-Schmidt R, Bojesen SE, Nordestgaard BG, Loft S, Tybjærg-Hansen A.

Pharmacogenomics J. 2011 Aug;11(4):292-9. doi: 10.1038/tpj.2010.38. Epub 2010 Jun 1.

PMID:
20514077
6.

Review of studies on metabolic genes and cancer in populations of African descent.

Ragin CC, Langevin S, Rubin S, Taioli E.

Genet Med. 2010 Jan;12(1):12-8. doi: 10.1097/GIM.0b013e3181c8e160. Review.

7.

Examination of polymorphic glutathione S-transferase (GST) genes, tobacco smoking and prostate cancer risk among men of African descent: a case-control study.

Lavender NA, Benford ML, VanCleave TT, Brock GN, Kittles RA, Moore JH, Hein DW, Kidd LC.

BMC Cancer. 2009 Nov 16;9:397. doi: 10.1186/1471-2407-9-397.

8.

An updating meta-analysis of the GSTM1, GSTT1, and GSTP1 polymorphisms and prostate cancer: a HuGE review.

Mo Z, Gao Y, Cao Y, Gao F, Jian L.

Prostate. 2009 May 1;69(6):662-88. doi: 10.1002/pros.20907. Review.

PMID:
19143011
9.

Uncertainty in heterogeneity estimates in meta-analyses.

Ioannidis JP, Patsopoulos NA, Evangelou E.

BMJ. 2007 Nov 3;335(7626):914-6. Review. No abstract available.

10.

African-Caribbean cancer consortium for the study of viral, genetic and environmental cancer risk factors.

Ragin CC, Taioli E, McFarlane-Anderson N, Avery G, Bennett F, Bovell-Benjamin A, Thompson AB, Carrington A, Campbell-Everett L, Ford J, Hennis A, Jackson M, Lake S, Leske MC, Magai C, Nemesure B, Neugut A, Odedina F, Okobia M, Patrick A, Plummer WB, Reams RR, Roberts R, Scott-Hastings S, Sharma S, Wheeler V, Wu SY, Bunker C.

Infect Agent Cancer. 2007 Sep 24;2:17.

11.

GSTM1 and GSTT1 polymorphisms and the risk of prostate cancer in a Caribbean population of African descent.

Mallick S, Romana M, Blanchet P, Multigner L.

Urology. 2007 Jun;69(6):1165-9.

PMID:
17572208
12.

Associations between smoking, polymorphisms in polycyclic aromatic hydrocarbon (PAH) metabolism and conjugation genes and PAH-DNA adducts in prostate tumors differ by race.

Nock NL, Tang D, Rundle A, Neslund-Dudas C, Savera AT, Bock CH, Monaghan KG, Koprowski A, Mitrache N, Yang JJ, Rybicki BA.

Cancer Epidemiol Biomarkers Prev. 2007 Jun;16(6):1236-45.

13.

Evaluation of genetic variations in the androgen and estrogen metabolic pathways as risk factors for sporadic and familial prostate cancer.

Cunningham JM, Hebbring SJ, McDonnell SK, Cicek MS, Christensen GB, Wang L, Jacobsen SJ, Cerhan JR, Blute ML, Schaid DJ, Thibodeau SN.

Cancer Epidemiol Biomarkers Prev. 2007 May;16(5):969-78.

14.

Prostate cancer characteristics in a multiracial community.

Ravery V, Dominique S, Hupertan V, Ben Rhouma S, Toublanc M, Boccon-Gibod L, Boccon-Gibod L.

Eur Urol. 2008 Mar;53(3):533-8. Epub 2007 Apr 23.

PMID:
17467885
15.

The risk of prostate cancer amongst black men in the United Kingdom: the PROCESS cohort study.

Ben-Shlomo Y, Evans S, Ibrahim F, Patel B, Anson K, Chinegwundoh F, Corbishley C, Dorling D, Thomas B, Gillatt D, Kirby R, Muir G, Nargund V, Popert R, Metcalfe C, Persad R; PROCESS study group.

Eur Urol. 2008 Jan;53(1):99-105. Epub 2007 Mar 1.

PMID:
17368710
16.

Prostate cancer risk from occupational exposure to polycyclic aromatic hydrocarbons interacting with the GSTP1 Ile105Val polymorphism.

Rybicki BA, Neslund-Dudas C, Nock NL, Schultz LR, Eklund L, Rosbolt J, Bock CH, Monaghan KG.

Cancer Detect Prev. 2006;30(5):412-22. Epub 2006 Oct 25.

17.

Polymorphisms in the glutathione S-transferase M1, T1, and P1 genes and prostate cancer prognosis.

Agalliu I, Lin DW, Salinas CA, Feng Z, Stanford JL.

Prostate. 2006 Oct 1;66(14):1535-41.

PMID:
16921513
18.

Joint effect among p53, CYP1A1, GSTM1 polymorphism combinations and smoking on prostate cancer risk: an exploratory genotype-environment interaction study.

Quiñones LA, Irarrázabal CE, Rojas CR, Orellana CE, Acevedo C, Huidobro C, Varela NE, Cáceres DD.

Asian J Androl. 2006 May;8(3):349-55.

19.

Glutathione S-transferase M1, T1, and P1 polymorphisms and prostate cancer risk in middle-aged men.

Agalliu I, Langeberg WJ, Lampe JW, Salinas CA, Stanford JL.

Prostate. 2006 Feb 1;66(2):146-56.

PMID:
16173036
20.

Prostate cancer and sexually transmitted diseases: a meta-analysis.

Taylor ML, Mainous AG 3rd, Wells BJ.

Fam Med. 2005 Jul-Aug;37(7):506-12.

Supplemental Content

Support Center